1. Home
  2. SFHG vs LNAI Comparison

SFHG vs LNAI Comparison

Compare SFHG & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$0.60

Market Cap

16.2M

ML Signal

HOLD

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

N/A

Current Price

$0.68

Market Cap

18.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SFHG
LNAI
Founded
1993
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
18.3M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
SFHG
LNAI
Price
$0.60
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
175.4K
288.1K
Earning Date
10-30-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,577,200.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.56
N/A
52 Week Low
$0.32
$0.63
52 Week High
$1.05
$14.00

Technical Indicators

Market Signals
Indicator
SFHG
LNAI
Relative Strength Index (RSI) 35.19 40.63
Support Level $0.59 $0.78
Resistance Level $0.75 $1.12
Average True Range (ATR) 0.06 0.12
MACD -0.01 0.00
Stochastic Oscillator 1.36 6.68

Price Performance

Historical Comparison
SFHG
LNAI

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: